2023 Q4 Form 10-K Financial Statement

#000106299323019828 Filed on October 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $835.3K $645.5K $2.611M
YoY Change 103.34% 23.28% 9.29%
% of Gross Profit
Research & Development $361.5K $96.71K $772.6K
YoY Change 191.58% -78.56% -2.03%
% of Gross Profit
Depreciation & Amortization $5.560K $5.850K $22.97K
YoY Change -1.59% -2.82% -5.67%
% of Gross Profit
Operating Expenses $1.227M $792.7K $3.533M
YoY Change 117.64% -21.01% 7.31%
Operating Profit
YoY Change
Interest Expense $63.54K $620.8K $328.1K
YoY Change -35.04% -331.1% 20.17%
% of Operating Profit
Other Income/Expense, Net $7.550K $10.83K $11.86K
YoY Change -83.14% -85.01%
Pretax Income -$1.378M -$161.0K -$3.660M
YoY Change 101.37% -86.67% 5.67%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.378M -$161.0K -$3.660M
YoY Change 101.37% -86.67% 5.67%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03 -$0.10
Diluted Earnings Per Share -$0.03 $0.00 -$0.10
COMMON SHARES
Basic Shares Outstanding 40.36M shares 36.39M shares
Diluted Shares Outstanding 40.36M shares 36.39M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $686.3K $758.3K $758.3K
YoY Change 311.41% 60.68% 60.68%
Cash & Equivalents $686.3K $758.3K
Short-Term Investments
Other Short-Term Assets $114.7K $140.0K $140.0K
YoY Change -68.7% -67.38% -67.38%
Inventory
Prepaid Expenses $114.7K $140.0K
Receivables $7.180K $82.53K $82.53K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $808.2K $980.8K $980.8K
YoY Change 33.29% -0.58% -0.58%
LONG-TERM ASSETS
Property, Plant & Equipment $522.9K $528.5K $4.678M
YoY Change -4.19% -4.17% -0.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.672M $4.678M $4.678M
YoY Change -0.49% -0.49% -0.49%
TOTAL ASSETS
Total Short-Term Assets $808.2K $980.8K $980.8K
Total Long-Term Assets $4.672M $4.678M $4.678M
Total Assets $5.480M $5.658M $5.658M
YoY Change 3.38% -0.5% -0.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $918.0K $457.4K $457.4K
YoY Change 88.07% 42.08% 42.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.001M $508.6K $508.6K
YoY Change 85.51% 45.32% 45.32%
LONG-TERM LIABILITIES
Long-Term Debt $1.532M $1.438M $1.438M
YoY Change 2.7% 5.38% 5.38%
Other Long-Term Liabilities $222.5K $140.0K $140.0K
YoY Change -37.49% -62.55% -62.55%
Total Long-Term Liabilities $1.754M $1.578M $1.578M
YoY Change -5.04% -9.23% -9.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.001M $508.6K $508.6K
Total Long-Term Liabilities $1.754M $1.578M $1.578M
Total Liabilities $2.755M $2.087M $2.087M
YoY Change 15.43% -0.09% -0.09%
SHAREHOLDERS EQUITY
Retained Earnings -$28.05M -$26.67M
YoY Change 18.38% 15.91%
Common Stock $40.36K $40.36K
YoY Change 23.1% 23.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.725M $3.572M $3.572M
YoY Change
Total Liabilities & Shareholders Equity $5.480M $5.658M $5.658M
YoY Change 3.38% -0.5% -0.5%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023
OPERATING ACTIVITIES
Net Income -$1.378M -$161.0K -$3.660M
YoY Change 101.37% -86.67% 5.67%
Depreciation, Depletion And Amortization $5.560K $5.850K $22.97K
YoY Change -1.59% -2.82% -5.67%
Cash From Operating Activities -$512.9K -$540.2K -$2.476M
YoY Change 68.09% -40.67% -8.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $250.0K
YoY Change
Cash From Financing Activities $440.9K 0.000 $2.763M
YoY Change 15.45%
NET CHANGE
Cash From Operating Activities -$512.9K -540.2K -$2.476M
Cash From Investing Activities $0.00
Cash From Financing Activities $440.9K 0.000 $2.763M
Net Change In Cash -$71.99K -540.2K $286.4K
YoY Change -76.41% -40.67% -195.02%
FREE CASH FLOW
Cash From Operating Activities -$512.9K -$540.2K -$2.476M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2985423 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2392998 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
406790 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2985423 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-3464127 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-978000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-887000 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
703000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1068000 usd
CY2023Q3 ryes Deferred Tax Assets Mineral Property Interest
DeferredTaxAssetsMineralPropertyInterest
-87000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3571861 usd
CY2023 dei Auditor Firm
AuditorFirmId
731
CY2023 dei Auditor Name
AuditorName
DAVIDSON & COMPANY LLP
CY2023 ryes Write Off On Payable
WriteOffOnPayable
0 usd
CY2022 ryes Write Off On Payable
WriteOffOnPayable
-30739 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2392998 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
250000 usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
27409 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27409 usd
CY2023 ryes Warrants Issued For Financing Expense
WarrantsIssuedForFinancingExpense
154218 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Use of Estimates</b></span></span></p> <p style="margin-left: 35.45pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant areas requiring the use of estimates include the carrying value and recoverability of mineral properties and the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences. Actual results could differ from those estimates and would impact future results of operations and cash flows.</span></span></p> </div>
CY2023 ryes Property Plant And Equipment Depreciation Method
PropertyPlantAndEquipmentDepreciationMethod
straight-line basis
CY2023Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P15Y
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-left: 36pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Concentration of credit risk</b></span></span></p> <p style="margin-left: 36pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The financial instrument which potentially subjects the Company to concentration of credit risk is cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. However, the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts.</span></span></p> </div>
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.14
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
6017500 shares
CY2022 ryes Warrants Issued Weighted Average Exercise Price
WarrantsIssuedWeightedAverageExercisePrice
0.76
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
531873 shares
CY2022 ryes Warrants Expired Weighted Average Exercise Price
WarrantsExpiredWeightedAverageExercisePrice
1.21
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6851379 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-3660382 usd
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
125000 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
101000 usd
CY2023 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-1391000 usd
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 usd
CY2023 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-1541000 usd
CY2022 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
282000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 ryes Deferred Tax Assets Exploration And Evaluation Assets
DeferredTaxAssetsExplorationAndEvaluationAssets
310000 usd
CY2022Q3 ryes Deferred Tax Assets Exploration And Evaluation Assets
DeferredTaxAssetsExplorationAndEvaluationAssets
49000 usd
CY2022Q3 ryes Deferred Tax Assets Mineral Property Interest
DeferredTaxAssetsMineralPropertyInterest
-21000 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4125000 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1630000 usd
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4348000 usd
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1658000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4348000 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1658000 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023 ryes Amount Paid To Lender
AmountPaidToLender
250000 usd

Files In Submission

Name View Source Status
0001062993-23-019828-index-headers.html Edgar Link pending
0001062993-23-019828-index.html Edgar Link pending
0001062993-23-019828.txt Edgar Link pending
0001062993-23-019828-xbrl.zip Edgar Link pending
exhibit10-9.htm Edgar Link pending
exhibit10-9x002.jpg Edgar Link pending
exhibit10-9xu001.jpg Edgar Link pending
exhibit23-1.htm Edgar Link pending
exhibit23-1xu002.jpg Edgar Link pending
exhibit23-1xu003.jpg Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kxz001.jpg Edgar Link pending
form10kxz002.jpg Edgar Link pending
form10kxz003.jpg Edgar Link pending
form10kxz004.jpg Edgar Link pending
form10kxz005.jpg Edgar Link pending
form10kxz006.jpg Edgar Link pending
form10kxz007.jpg Edgar Link pending
form10kxz008.jpg Edgar Link pending
form10kxz009.jpg Edgar Link pending
form10kxz010.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10k_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ryes-20230731.xsd Edgar Link pending
Show.js Edgar Link pending
ryes-20230731_cal.xml Edgar Link unprocessable
ryes-20230731_def.xml Edgar Link unprocessable
ryes-20230731_lab.xml Edgar Link unprocessable
ryes-20230731_pre.xml Edgar Link unprocessable